Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
Saved in:
| Title: | Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates. |
|---|---|
| Authors: | Pittman, Phillip R.1 phillip.r.pittman.civ@mail.mil, Norris, Sarah L.1, Brown, Elizabeth S.2, Ranadive, Manmohan V.3, Schibly, Barbara A.3, Bettinger, George E.4, Lokugamage, Nandadeva4, Korman, Lawrence1, Morrill, John C.4, Peters, Clarence J.4 |
| Source: | Vaccine. Jan2016, Vol. 34 Issue 4, p523-530. 8p. |
| Database: | Environment Complete |
| ISSN: | 0264410X |
|---|---|
| DOI: | 10.1016/j.vaccine.2015.11.078 |
